A first-of-its-kind drug targeting a fused gene found in many types of cancer was effective in 93 percent of pediatric patients tested, researchers say. A first-of-its-kind drug targeting a fused gene ...
ROCKVILLE, Md., July 31, 2024 (GLOBE NEWSWIRE) -- Theriva™ Biologics, Inc. (NYSE American: TOVX), a diversified clinical-stage company developing therapeutics designed to treat cancer and related ...
Introduction Pediatric Pharmacology Disasters Testing Drugs in Children Legal and Regulatory Developments: Pediatric Pharmacology in the United States References Legal and Regulatory Developments: ...
Despite groundbreaking advances in pediatric cancer research, many promising therapies never reach the children who need them most. Catherine Bollard, MD, is senior vice president and chief research ...
The FDA has accepted for review the sBLA for Afrezza (insulin human) inhalation powder in children and adolescents with type 1 or 2 diabetes.
ROCKVILLE, Md., May 24, 2022 (GLOBE NEWSWIRE) -- Neuronascent Inc., a clinical-stage biopharmaceutical company discovering and developing neuron-generating therapies for rare developmental disorders, ...
In research led by a University at Buffalo pediatric endocrinologist, a drug called golimumab showed that it preserved beta-cell function in children and young adults with newly diagnosed Type 1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback